Three pillars for
Coral's approach
Low cost assays for data generation
Industry leading COGS (5-fold savings) for clinical exome, gene panel sequencing, and genotyping. Scalable workflows for primary cell genomic assays.
New clinical tests
Developing tests that predict response to autoimmune medications and improve cardiovascular disease risk predictions.
Anti-precision medicine
Creating drugs that improve response rates of existing therapies towards a "one drug, all patients" paradigm.
